Biolife Solutions (BLFS) Return on Capital Employed (2011 - 2026)

Biolife Solutions (BLFS) has 16 years of Return on Capital Employed data on file, last reported at 3.99% in Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 353.0% year-over-year to 3.99% in Q1 2026; TTM through Mar 2026 was 3.99%, a 353.0% decrease from a year earlier, with the FY2025 full-year figure at 4.37%, down 317.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 3.99%, up from 4.22% in the prior quarter.
• Over the last five years, Return on Capital Employed for BLFS reached as high as 13.59% in Q2 2023 and fell as low as 26.14% in Q3 2022.
• Historically, Return on Capital Employed has averaged 3.62% across 5 years, with a median of 3.22% in 2024.
• Across the five-year window, Return on Capital Employed sank 2176 bps in 2022 and soared 3948 bps in 2023, its largest moves.
• Year by year, Return on Capital Employed stood at 1.4% in 2022, then plunged by 330 bps to 6.0% in 2023, then soared by 79 bps to 1.25% in 2024, then sank by 238 bps to 4.22% in 2025, then advanced by 6 bps to 3.99% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 3.99% in Q1 2026, 4.22% in Q4 2025, and 4.6% in Q3 2025.